Covid vaccine behind increased sudden deaths of young Indians? Here is what ICMR study revealed
The ICMR study revealed that two doses of Covid vaccine actually lowered the risk of sudden deaths while one doses didn't have any such effect.
The ICMR study revealed that two doses of Covid vaccine actually lowered the risk of sudden deaths while one doses didn't have any such effect.
Actor Manoj Bajpayee has shared what motivated him to come on board the documentary 'The Vial', which is all about the development of the Covid vaccine.
The report stated that ICMR and CDSCO officials have cited a plethora of ramifications arising out of all the COVID vaccines.
The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
As part of the programme, 1 lakh vaccination centres across the state would inoculate individuals.
The US Food and Drug Administration (FDA) advisory committee voted unanimously on Friday to recommend authorization of the second dose as early as two months after the primary shot for anyone aged 18 and older.
Covovax is the Indian version of the Novovax vaccine brought in India by the Serum Institute of India for children.
The research provides an insight into the safety of additional vaccine shots as the US rolls out a booster regimen for older adults and workers in high-risk jobs, the Washington Post reported.
The panel on Thursday voted 15-0 to recommend the booster dose for Americans age 65 and older and people in long-term care facilities
The Sputnik Light vaccine in India is produced by Hetero Biopharma which is one of the Russian Direct Investment Fund partners in the production of the vaccine.
